Engineering a dirhodium artificial metalloenzyme for selective olefin cyclopropanation
P Srivastava, H Yang, K Ellis-Guardiola… - Nature …, 2015 - nature.com
Artificial metalloenzymes (ArMs) formed by incorporating synthetic metal catalysts into
protein scaffolds have the potential to impart to chemical reactions selectivity that would be …
protein scaffolds have the potential to impart to chemical reactions selectivity that would be …
New tricks of prolyl oligopeptidase inhibitors–a common drug therapy for several neurodegenerative diseases
R Svarcbahs, U Julku, T Kilpeläinen, M Kyyrö… - Biochemical …, 2019 - Elsevier
Abstract Changes in prolyl oligopeptidase (PREP) expression levels, protein distribution,
and activity correlate with aging and are reported in many neurodegenerative conditions …
and activity correlate with aging and are reported in many neurodegenerative conditions …
[HTML][HTML] The effect of prolyl oligopeptidase inhibitors on alpha-synuclein aggregation and autophagy cannot be predicted by their inhibitory efficacy
TP Kilpeläinen, L Hellinen, J Vrijdag, X Yan… - Biomedicine & …, 2020 - Elsevier
Previous studies have shown that prolyl oligopeptidase (PREP) negatively regulates
autophagy and increases the aggregation of alpha-synuclein (αSyn), linking it to the …
autophagy and increases the aggregation of alpha-synuclein (αSyn), linking it to the …
Unraveling the allosteric mechanisms of prolyl endopeptidases for celiac disease therapy: Insights from molecular dynamics simulations
Y Wang, S Xing, X Zhao, X Chen, C Zhan - International Journal of …, 2024 - Elsevier
Prolyl endopeptidases (PEP) from Sphingomonas capsulata (sc) and Myxococcus xanthus
(mx) selectively degrade gluten peptides in vitro, offering a potential therapeutic strategy for …
(mx) selectively degrade gluten peptides in vitro, offering a potential therapeutic strategy for …
Virtual screening and computational optimization for the discovery of covalent prolyl oligopeptidase inhibitors with activity in human cells
S De Cesco, S Deslandes, E Therrien… - Journal of Medicinal …, 2012 - ACS Publications
Our docking program, Fitted, implemented in our computational platform, Forecaster, has
been modified to carry out automated virtual screening of covalent inhibitors. With this …
been modified to carry out automated virtual screening of covalent inhibitors. With this …
Crystal Structure and Conformational Dynamics of Pyrococcus furiosus Prolyl Oligopeptidase
K Ellis-Guardiola, H Rui, RL Beckner, P Srivastava… - Biochemistry, 2019 - ACS Publications
Enzymes in the prolyl oligopeptidase family possess unique structures and substrate
specificities that are important for their biological activity and for potential biocatalytic …
specificities that are important for their biological activity and for potential biocatalytic …
Crystal Structures of Trypanosoma brucei Oligopeptidase B Broaden the Paradigm of Catalytic Regulation in Prolyl Oligopeptidase Family Enzymes
P Canning, D Rea, RE Morty, V Fülöp - PloS one, 2013 - journals.plos.org
Oligopeptidase B cleaves after basic amino acids in peptides up to 30 residues. As a
virulence factor in bacteria and trypanosomatid pathogens that is absent in higher …
virulence factor in bacteria and trypanosomatid pathogens that is absent in higher …
The loops facing the active site of prolyl oligopeptidase are crucial components in substrate gating and specificity
Z Szeltner, T Juhász, I Szamosi, D Rea, V Fülöp… - … et Biophysica Acta (BBA …, 2013 - Elsevier
Prolyl oligopeptidase (POP) has emerged as a drug target for neurological diseases. A
flexible loop structure comprising loop A (res. 189–209) and loop B (res. 577–608) at the …
flexible loop structure comprising loop A (res. 189–209) and loop B (res. 577–608) at the …
Dynamics and ligand-induced conformational changes in human prolyl oligopeptidase analyzed by hydrogen/deuterium exchange mass spectrometry
A Tsirigotaki, RV Elzen, PVD Veken, AM Lambeir… - Scientific Reports, 2017 - nature.com
Prolyl oligopeptidase (PREP) is conserved in many organisms across life. It is involved in
numerous processes including brain function and neuropathology, that require more than its …
numerous processes including brain function and neuropathology, that require more than its …
Peptide POP inhibitors for the treatment of the cognitive symptoms of schizophrenia
A Lopez, L Mendieta, R Prades, S Royo… - Future Medicinal …, 2013 - Taylor & Francis
Schizophrenia is a serious life-long disease that affects a significant part of the adult
population. Although there is considerably effective medication for the positive symptoms of …
population. Although there is considerably effective medication for the positive symptoms of …